Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

STAT6 Monoclonal Antibody is Highly Specific for the Distinction between Solitary Fibrous Tumour and Prostatic Stromal Proliferations.

Cox RM, Chan E, Sangoi AR, Zou Y, McKenney JK.

Histopathology. 2019 Sep 9. doi: 10.1111/his.13988. [Epub ahead of print]

PMID:
31498908
2.

Variability of CD34 Expression in Sinonasal Glomangiopericytoma: A Potential Diagnostic Pitfall.

Sangoi AR, Bishop JA.

Head Neck Pathol. 2019 Aug 9. doi: 10.1007/s12105-019-01063-9. [Epub ahead of print]

PMID:
31399905
3.

Urothelial Carcinoma In Situ With Plasmacytoid Features: A Clinicopathologic Study of 23 Cases.

Sangoi AR, Falzarano SM, Nicolas M, McKenney JK.

Am J Surg Pathol. 2019 Jul 29. doi: 10.1097/PAS.0000000000001318. [Epub ahead of print]

PMID:
31368912
4.

Development and validation of a deep learning algorithm for improving Gleason scoring of prostate cancer.

Nagpal K, Foote D, Liu Y, Chen PC, Wulczyn E, Tan F, Olson N, Smith JL, Mohtashamian A, Wren JH, Corrado GS, MacDonald R, Peng LH, Amin MB, Evans AJ, Sangoi AR, Mermel CH, Hipp JD, Stumpe MC.

NPJ Digit Med. 2019 Jun 7;2:48. doi: 10.1038/s41746-019-0112-2. eCollection 2019.

5.

Low-grade oncocytic tumour of kidney (CD117-negative, cytokeratin 7-positive): a distinct entity?

Trpkov K, Williamson SR, Gao Y, Martinek P, Cheng L, Sangoi AR, Yilmaz A, Wang C, San Miguel Fraile P, Perez Montiel DM, Bulimbasić S, Rogala J, Hes O.

Histopathology. 2019 Aug;75(2):174-184. doi: 10.1111/his.13865. Epub 2019 Mar 21.

PMID:
30895640
6.

VSTM2A Overexpression Is a Sensitive and Specific Biomarker for Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) of the Kidney.

Wang L, Zhang Y, Chen YB, Skala SL, Al-Ahmadie HA, Wang X, Cao X, Veeneman BA, Chen J, Cieślik M, Qiao Y, Su F, Vats P, Siddiqui J, Xiao H, Sadimin ET, Epstein JI, Zhou M, Sangoi AR, Trpkov K, Osunkoya AO, Giannico GA, McKenney JK, Argani P, Tickoo SK, Reuter VE, Chinnaiyan AM, Dhanasekaran SM, Mehra R.

Am J Surg Pathol. 2018 Dec;42(12):1571-1584. doi: 10.1097/PAS.0000000000001150.

PMID:
30285995
7.

DICER1 mutations are frequent in müllerian adenosarcomas and are independent of rhabdomyosarcomatous differentiation.

Bean GR, Anderson J, Sangoi AR, Krings G, Garg K.

Mod Pathol. 2019 Feb;32(2):280-289. doi: 10.1038/s41379-018-0132-5. Epub 2018 Sep 28.

PMID:
30266945
8.

Acquired Cystic Disease-associated Renal Cell Carcinoma (ACD-RCC): A Multiinstitutional Study of 40 Cases With Clinical Follow-up.

Przybycin CG, Harper HL, Reynolds JP, Magi-Galluzzi C, Nguyen JK, Wu A, Sangoi AR, Liu PS, Umar S, Mehra R, Zhang X, Cox RM, McKenney JK.

Am J Surg Pathol. 2018 Sep;42(9):1156-1165. doi: 10.1097/PAS.0000000000001091.

PMID:
29851703
9.

Angiomyomatous hamartoma of lymph nodes, revisited: clinicopathologic study of 21 cases, emphasizing its distinction from lymphangioleiomyomatosis of lymph nodes.

Moh M, Sangoi AR, Rabban JT.

Hum Pathol. 2017 Oct;68:175-183. doi: 10.1016/j.humpath.2017.08.035. Epub 2017 Sep 9.

PMID:
28899738
10.

FOXL2 Mutation Status in Granulosa Theca Cell Tumors of the Ovary.

Nolan A, Joseph NM, Sangoi AR, Rabban J, Zaloudek C, Garg K.

Int J Gynecol Pathol. 2017 Nov;36(6):568-574. doi: 10.1097/PGP.0000000000000377.

PMID:
28319575
11.

Interobserver Reproducibility Among Gynecologic Pathologists in Diagnosing Heterologous Osteosarcomatous Component in Gynecologic Tract Carcinosarcomas.

Sangoi AR, Kshirsagar M, Roma AA, Horvai AE, Chivukula M, Ellenson LH, Fadare O, Folkins AK, Garg K, Hanley K, Longacre TA, Haas J, McCluggage WG, McKenney JK, Nucci MR, Oliva E, Park KJ, Parkash V, Quick CM, Rabban JT, Rutgers JKL, Soslow R, Vang R, Yemelyanova A, Zaloudek C, Beck AH.

Int J Gynecol Pathol. 2017 Jul;36(4):386-392. doi: 10.1097/PGP.0000000000000329.

PMID:
28221217
12.

Biallelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney.

Mehra R, Vats P, Cieslik M, Cao X, Su F, Shukla S, Udager AM, Wang R, Pan J, Kasaian K, Lonigro R, Siddiqui J, Premkumar K, Palapattu G, Weizer A, Hafez KS, Wolf JS Jr, Sangoi AR, Trpkov K, Osunkoya AO, Zhou M, Giannico G, McKenney JK, Dhanasekaran SM, Chinnaiyan AM.

Cancer Discov. 2016 Nov;6(11):1258-1266. Epub 2016 Sep 7.

13.

Tuberous sclerosis complex: Hamartin and tuberin expression in renal cysts and its discordant expression in renal neoplasms.

Bonsib SM, Boils C, Gokden N, Grignon D, Gu X, Higgins JP, Leroy X, McKenney JK, Nasr SH, Phillips C, Sangoi AR, Wilson J, Zhang PL.

Pathol Res Pract. 2016 Nov;212(11):972-979. doi: 10.1016/j.prp.2016.04.005. Epub 2016 Apr 30.

14.

SATB2 Expression Is Sensitive but Not Specific for Osteosarcomatous Components of Gynecologic Tract Carcinosarcomas: A Clinicopathologic Study of 60 Cases.

Sangoi AR, Kshirsagar M, Horvai AE, Roma AA.

Int J Gynecol Pathol. 2017 Mar;36(2):140-145. doi: 10.1097/PGP.0000000000000301.

PMID:
27294605
15.

The Novel Marker GATA3 is Significantly More Sensitive Than Traditional Markers Mammaglobin and GCDFP15 for Identifying Breast Cancer in Surgical and Cytology Specimens of Metastatic and Matched Primary Tumors.

Sangoi AR, Shrestha B, Yang G, Mego O, Beck AH.

Appl Immunohistochem Mol Morphol. 2016 Apr;24(4):229-37. doi: 10.1097/PAI.0000000000000186. Review.

16.
17.

Renal leiomyoma: a contemporary multi-institution study of an infrequent and frequently misclassified neoplasm.

Patil PA, McKenney JK, Trpkov K, Hes O, Montironi R, Scarpelli M, Nesi G, Aron M, Sangoi AR, Gattuso P, Magi-Galluzzi C.

Am J Surg Pathol. 2015 Mar;39(3):349-56. doi: 10.1097/PAS.0000000000000354. Review.

PMID:
25517956
18.

Androgen receptor immunohistochemistry in genitourinary neoplasms.

Williams EM, Higgins JP, Sangoi AR, McKenney JK, Troxell ML.

Int Urol Nephrol. 2015 Jan;47(1):81-5. doi: 10.1007/s11255-014-0834-7. Epub 2014 Sep 14.

PMID:
25218615
19.

Prostate adenocarcinomas aberrantly expressing p63 are molecularly distinct from usual-type prostatic adenocarcinomas.

Tan HL, Haffner MC, Esopi DM, Vaghasia AM, Giannico GA, Ross HM, Ghosh S, Hicks JL, Zheng Q, Sangoi AR, Yegnasubramanian S, Osunkoya AO, De Marzo AM, Epstein JI, Lotan TL.

Mod Pathol. 2015 Mar;28(3):446-56. doi: 10.1038/modpathol.2014.115. Epub 2014 Sep 12.

20.

Tuberous sclerosis-associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patients.

Guo J, Tretiakova MS, Troxell ML, Osunkoya AO, Fadare O, Sangoi AR, Shen SS, Lopez-Beltran A, Mehra R, Heider A, Higgins JP, Harik LR, Leroy X, Gill AJ, Trpkov K, Campbell SC, Przybycin C, Magi-Galluzzi C, McKenney JK.

Am J Surg Pathol. 2014 Nov;38(11):1457-67. doi: 10.1097/PAS.0000000000000248.

PMID:
25093518
21.

PAX-8 expression in primary and metastatic Merkel cell carcinoma: an immunohistochemical analysis.

Sangoi AR, Cassarino DS.

Am J Dermatopathol. 2013 Jun;35(4):448-51. doi: 10.1097/DAD.0b013e318271ce53.

PMID:
23612030
22.

Evaluation of SF-1 expression in testicular germ cell tumors: a tissue microarray study of 127 cases.

Sangoi AR, McKenney JK, Brooks JD, Higgins JP.

Appl Immunohistochem Mol Morphol. 2013 Jul;21(4):318-21. doi: 10.1097/PAI.0b013e318277cf5a.

PMID:
23165333
23.

Evaluation of putative renal cell carcinoma markers PAX-2, PAX-8, and hKIM-1 in germ cell tumors: a tissue microarray study of 100 cases.

Sangoi AR, McKenney JK, Brooks JD, Bonventre JV, Higgins JP.

Appl Immunohistochem Mol Morphol. 2012 Oct;20(5):451-3. doi: 10.1097/PAI.0b013e31824bb404.

24.

In reply.

Sangoi AR, McKenney JK.

Adv Anat Pathol. 2012 Mar;19(2):128. doi: 10.1097/PAP.0b013e31824dafb3. No abstract available.

PMID:
22313841
25.

Plasmacytoid carcinoma of the bladder: a urothelial carcinoma variant with a predilection for intraperitoneal spread.

Ricardo-Gonzalez RR, Nguyen M, Gokden N, Sangoi AR, Presti JC Jr, McKenney JK.

J Urol. 2012 Mar;187(3):852-5. doi: 10.1016/j.juro.2011.10.145. Epub 2012 Jan 15.

PMID:
22245324
26.

Systematic analysis of breast cancer morphology uncovers stromal features associated with survival.

Beck AH, Sangoi AR, Leung S, Marinelli RJ, Nielsen TO, van de Vijver MJ, West RB, van de Rijn M, Koller D.

Sci Transl Med. 2011 Nov 9;3(108):108ra113. doi: 10.1126/scitranslmed.3002564.

27.

Immunohistochemical distinction of primary adrenal cortical lesions from metastatic clear cell renal cell carcinoma: a study of 248 cases.

Sangoi AR, Fujiwara M, West RB, Montgomery KD, Bonventre JV, Higgins JP, Rouse RV, Gokden N, McKenney JK.

Am J Surg Pathol. 2011 May;35(5):678-86. doi: 10.1097/PAS.0b013e3182152629.

28.
29.

Specificity of brachyury in the distinction of chordoma from clear cell renal cell carcinoma and germ cell tumors: a study of 305 cases.

Sangoi AR, Karamchandani J, Lane B, Higgins JP, Rouse RV, Brooks JD, McKenney JK.

Mod Pathol. 2011 Mar;24(3):425-9. doi: 10.1038/modpathol.2010.196. Epub 2010 Nov 19.

30.

The use of immunohistochemistry in the diagnosis of metastatic clear cell renal cell carcinoma: a review of PAX-8, PAX-2, hKIM-1, RCCma, and CD10.

Sangoi AR, Karamchandani J, Kim J, Pai RK, McKenney JK.

Adv Anat Pathol. 2010 Nov;17(6):377-93. doi: 10.1097/PAP.0b013e3181f89400. Review.

PMID:
20966644
31.

PAX8 expression reliably distinguishes pancreatic well-differentiated neuroendocrine tumors from ileal and pulmonary well-differentiated neuroendocrine tumors and pancreatic acinar cell carcinoma.

Sangoi AR, Ohgami RS, Pai RK, Beck AH, McKenney JK, Pai RK.

Mod Pathol. 2011 Mar;24(3):412-24. doi: 10.1038/modpathol.2010.176. Epub 2010 Oct 1.

32.

Interobserver reproducibility in the diagnosis of invasive micropapillary carcinoma of the urinary tract among urologic pathologists.

Sangoi AR, Beck AH, Amin MB, Cheng L, Epstein JI, Hansel DE, Iczkowski KA, Lopez-Beltran A, Oliva E, Paner GP, Reuter VE, Ro JY, Shah RB, Shen SS, Tamboli P, McKenney JK.

Am J Surg Pathol. 2010 Sep;34(9):1367-76. doi: 10.1097/PAS.0b013e3181ec86b3.

PMID:
20717002
33.

The distribution of PAX-2 immunoreactivity in the prostate gland, seminal vesicle, and ejaculatory duct: comparison with prostatic adenocarcinoma and discussion of prostatic zonal embryogenesis.

Quick CM, Gokden N, Sangoi AR, Brooks JD, McKenney JK.

Hum Pathol. 2010 Aug;41(8):1145-9. doi: 10.1016/j.humpath.2010.01.010. Epub 2010 Apr 22.

PMID:
20413145
34.
35.

Adenomatoid tumors of the female and male genital tracts: a clinicopathological and immunohistochemical study of 44 cases.

Sangoi AR, McKenney JK, Schwartz EJ, Rouse RV, Longacre TA.

Mod Pathol. 2009 Sep;22(9):1228-35. doi: 10.1038/modpathol.2009.90. Epub 2009 Jun 19.

36.

Invasive urothelial carcinoma with chordoid features: a report of 12 distinct cases characterized by prominent myxoid stroma and cordlike epithelial architecture.

Cox RM, Schneider AG, Sangoi AR, Clingan WJ, Gokden N, McKenney JK.

Am J Surg Pathol. 2009 Aug;33(8):1213-9. doi: 10.1097/PAS.0b013e3181a8ffbe.

PMID:
19542871
37.

Immunohistochemical comparison of MUC1, CA125, and Her2Neu in invasive micropapillary carcinoma of the urinary tract and typical invasive urothelial carcinoma with retraction artifact.

Sangoi AR, Higgins JP, Rouse RV, Schneider AG, McKenney JK.

Mod Pathol. 2009 May;22(5):660-7. doi: 10.1038/modpathol.2009.16. Epub 2009 Mar 6.

38.

Challenges and pitfalls of morphologic identification of fungal infections in histologic and cytologic specimens: a ten-year retrospective review at a single institution.

Sangoi AR, Rogers WM, Longacre TA, Montoya JG, Baron EJ, Banaei N.

Am J Clin Pathol. 2009 Mar;131(3):364-75. doi: 10.1309/AJCP99OOOZSNISCZ.

PMID:
19228642
39.

Distinguishing chordoid meningiomas from their histologic mimics: an immunohistochemical evaluation.

Sangoi AR, Dulai MS, Beck AH, Brat DJ, Vogel H.

Am J Surg Pathol. 2009 May;33(5):669-81. doi: 10.1097/PAS.0b013e318194c566.

40.

Suprasellar giant cell ependymoma: a rare neoplasm in a unique location.

Sangoi AR, Lim M, Dulai M, Vogel H, Chang S.

Hum Pathol. 2008 Sep;39(9):1396-401. doi: 10.1016/j.humpath.2008.01.007. Epub 2008 Jul 7.

PMID:
18602668
41.

Ovarian clear cell carcinoma with papillary features: a potential mimic of serous tumor of low malignant potential.

Sangoi AR, Soslow RA, Teng NN, Longacre TA.

Am J Surg Pathol. 2008 Feb;32(2):269-74. doi: 10.1097/PAS.0b013e31814fa9b0.

PMID:
18223330
42.

Lymphatic vascular invasion in ovarian serous tumors of low malignant potential with stromal microinvasion: a case control study.

Sangoi AR, McKenney JK, Dadras SS, Longacre TA.

Am J Surg Pathol. 2008 Feb;32(2):261-8. doi: 10.1097/PAS.0b013e318141fc7a.

PMID:
18223329
43.
44.

Supplemental Content

Loading ...
Support Center